136 related articles for article (PubMed ID: 34929597)
21. N-cadherin expression is correlated with metastasis of spindle cell carcinoma of head and neck region.
Nguyen PT; Kudo Y; Yoshida M; Iizuka S; Ogawa I; Takata T
J Oral Pathol Med; 2011 Jan; 40(1):77-82. PubMed ID: 21070371
[TBL] [Abstract][Full Text] [Related]
22. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
23. Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1.
Lewis JS; Ritter JH; El-Mofty S
Mod Pathol; 2005 Nov; 18(11):1471-81. PubMed ID: 15976812
[TBL] [Abstract][Full Text] [Related]
24. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology.
Khazai L; Agosto-Arroyo E; Rosa M
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):599-604. PubMed ID: 28549030
[TBL] [Abstract][Full Text] [Related]
25. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
Wang X; Boddicker RL; Dasari S; Sidhu JS; Kadin ME; Macon WR; Ansell SM; Ketterling RP; Rech KL; Feldman AL
Hum Pathol; 2017 Jun; 64():19-27. PubMed ID: 28153507
[TBL] [Abstract][Full Text] [Related]
26. Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast.
Sailer V; Lüders C; Kuhn W; Pelzer V; Kristiansen G
Virchows Arch; 2015 Jul; 467(1):67-70. PubMed ID: 25850754
[TBL] [Abstract][Full Text] [Related]
27. Increased numbers of P63-positive/CD117-positive cells in advanced adenoid cystic carcinoma give a poorer prognosis.
Zhou Q; Chang H; Zhang H; Han Y; Liu H
Diagn Pathol; 2012 Sep; 7():119. PubMed ID: 22963430
[TBL] [Abstract][Full Text] [Related]
28. Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
Kriegsmann K; Cremer M; Zgorzelski C; Harms A; Muley T; Winter H; Kazdal D; Warth A; Kriegsmann M
Pathology; 2019 Apr; 51(3):240-245. PubMed ID: 30798982
[TBL] [Abstract][Full Text] [Related]
29. Differentiating Small Cell Carcinoma From Squamous Cell Carcinoma in Cytologic Specimens: A Head-to-Head Comparison of p40 and p63 Using Cell Block Immunocytochemistry.
Gailey MP; Bellizzi AM; Jensen CS
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):11-5. PubMed ID: 25906121
[TBL] [Abstract][Full Text] [Related]
30. Spindle cell carcinoma of head and neck: an immunohistochemical and molecular approach to its pathogenesis.
Gupta R; Singh S; Hedau S; Nigam S; Das BC; Singh I; Mandal AK
J Clin Pathol; 2007 May; 60(5):472-5. PubMed ID: 16731596
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma.
Srinivasan M; Parwani AV
Diagn Pathol; 2011 Jul; 6():67. PubMed ID: 21777423
[TBL] [Abstract][Full Text] [Related]
32. p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies.
Henderson SA; Torres-Cabala CA; Curry JL; Bassett RL; Ivan D; Prieto VG; Tetzlaff MT
Am J Surg Pathol; 2014 Aug; 38(8):1102-10. PubMed ID: 25029117
[TBL] [Abstract][Full Text] [Related]
33. Expression of P63 and its correlation with prognosis in diffuse large B-cell lymphoma: a single center experience.
Hu WM; Jin JT; Wu CY; Lu JB; Zhang LH; Zeng J; Lin SX
Diagn Pathol; 2019 Nov; 14(1):128. PubMed ID: 31711519
[TBL] [Abstract][Full Text] [Related]
34. Benign and malignant odontogenic neoplasms of the jaws show a concordant nondiscriminatory p63/p40 positive immunophenotype.
Argyris PP; Malz C; Taleb R; Koutlas IG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Dec; 126(6):506-512. PubMed ID: 30309829
[TBL] [Abstract][Full Text] [Related]
35. Utility of p40 in the Differential Diagnosis of Small Round Blue Cell Tumors of the Sinonasal Tract.
Tilson MP; Bishop JA
Head Neck Pathol; 2014 Jun; 8(2):141-5. PubMed ID: 24114197
[TBL] [Abstract][Full Text] [Related]
36. Occasional staining for p63 in malignant vascular tumors: a potential diagnostic pitfall.
Kallen ME; Nunes Rosado FG; Gonzalez AL; Sanders ME; Cates JM
Pathol Oncol Res; 2012 Jan; 18(1):97-100. PubMed ID: 21667345
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and immunohistochemical features of oral spindle cell carcinoma.
Romañach MJ; Azevedo RS; Carlos R; de Almeida OP; Pires FR
J Oral Pathol Med; 2010 Apr; 39(4):335-41. PubMed ID: 20002980
[TBL] [Abstract][Full Text] [Related]
38. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
[TBL] [Abstract][Full Text] [Related]
39. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
40. Greater specificity of p40 compared with p63 in distinguishing squamous cell carcinoma from adenocarcinoma in effusion cellblocks.
Kim NI; Lee JS
Cytojournal; 2020; 17():13. PubMed ID: 32636920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
